Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_000088.3(COL1A1):c.3028G>A (p.Gly1010Ser) | 1277 | COL1A1 | Pathogenic | 72653169 | RCV000018836; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 17 | 48266281 | 48266281 | NM_000088.3:c.3028G>A | NP_000079.2:p.Gly1010Ser | NC_000017.10:g.48266281C>T | OMIM Allelic Variant:120150.0012 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000088.3(COL1A1):c.1057G>T (p.Gly353Cys) | 1277 | COL1A1 | Pathogenic | 66721653 | RCV000018827; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 17 | 48273026 | 48273026 | NM_000088.3:c.1057G>T | NP_000079.2:p.Gly353Cys | NC_000017.10:g.48273026C>A | OMIM Allelic Variant:120150.0003 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000088.3(COL1A1):c.91C>T (p.Gln31Ter) | 1277 | COL1A1 | Pathogenic | 794726873 | RCV000173063; RCV000173062; | N | MedGen:C0023931,OMIM:166200,SNOMED CT:385482004; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 17 | 48278784 | 48278784 | NM_000088.3:c.91C>T | NP_000079.2:p.Gln31Ter | NC_000017.10:g.48278784G>A | - | C0023931 166200 Osteogenesis imperfecta type I; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.1136G>C (p.Gly379Ala) | 1278 | COL1A2 | Pathogenic | 121912912 | RCV000018819; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94039778 | 94039778 | NM_000089.3:c.1136G>C | NP_000080.2:p.Gly379Ala | NC_000007.13:g.94039778G>C | OMIM Allelic Variant:120160.0050 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.1757G>T (p.Gly586Val) | 1278 | COL1A2 | Pathogenic | 121912907 | RCV000018794; RCV000018793; | N | MedGen:C0268362,OMIM:259420,ORPHA:216812,SNOMED CT:385483009; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94044575 | 94044575 | NM_000089.3:c.1757G>T | NP_000080.2:p.Gly586Val | NC_000007.13:g.94044575G>T | OMIM Allelic Variant:120160.0023,OMIM Allelic Variant:120160.0038 | C0268362 259420 Osteogenesis imperfecta type III; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.1936G>T (p.Gly646Cys) | 1278 | COL1A2 | Pathogenic | 121912903 | RCV000018783; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94047108 | 94047108 | NM_000089.3:c.1936G>T | NP_000080.2:p.Gly646Cys | NC_000007.13:g.94047108G>T | OMIM Allelic Variant:120160.0013 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.1971+1G>A | 1278 | COL1A2 | Pathogenic | 72658151 | RCV000177588; RCV000177589; | N | MedGen:C0268362,OMIM:259420,ORPHA:216812,SNOMED CT:385483009; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94047144 | 94047144 | NM_000089.3:c.1971+1G>A | | NC_000007.13:g.94047144G>A | - | C0268362 259420 Osteogenesis imperfecta type III; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.2099G>A (p.Gly700Asp) | 1278 | COL1A2 | Pathogenic | 72658161 | RCV000177822; RCV000177823; | N | MedGen:C0268362,OMIM:259420,ORPHA:216812,SNOMED CT:385483009; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94049564 | 94049564 | NM_000089.3:c.2099G>A | NP_000080.2:p.Gly700Asp | NC_000007.13:g.94049564G>A | - | C0268362 259420 Osteogenesis imperfecta type III; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.2957C>T (p.Pro986Leu) | 1278 | COL1A2 | Likely pathogenic | 768171831 | RCV000199225; | N | MedGen:C0268360,OMIM:166210,SNOMED CT:86470003; MedGen:C0268362,OMIM:259420,ORPHA:216812,SNOMED CT:385483009; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94055323 | 94055323 | NM_000089.3:c.2957C>T | NP_000080.2:p.Pro986Leu | NC_000007.13:g.94055323C>T | - | C0268362 259420 Osteogenesis imperfecta type III; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form; C0268360 166210 Osteogenesis imperfecta, recessive perinatal lethal | | |
NM_000089.3(COL1A2):c.3034G>C (p.Gly1012Arg) | 1278 | COL1A2 | Pathogenic | 72659319 | RCV000018775; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94055771 | 94055771 | NM_000089.3:c.3034G>C | NP_000080.2:p.Gly1012Arg | NC_000007.13:g.94055771G>A,NC_000007.13:g.94055771G>C | OMIM Allelic Variant:120160.0004 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |
NM_000089.3(COL1A2):c.3034G>A (p.Gly1012Ser) | 1278 | COL1A2 | Likely pathogenic | 72659319 | RCV000197038; | N | MedGen:C0268360,OMIM:166210,SNOMED CT:86470003; MedGen:C0268362,OMIM:259420,ORPHA:216812,SNOMED CT:385483009; MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94055771 | 94055771 | NM_000089.3:c.3034G>A | NP_000080.2:p.Gly1012Ser | NC_000007.13:g.94055771G>A,NC_000007.13:g.94055771G>C | - | C0268362 259420 Osteogenesis imperfecta type III; C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form; C0268360 166210 Osteogenesis imperfecta, recessive perinatal lethal | | |
NM_000089.3(COL1A2):c.3279_3287delTCCCCCTGG (p.Pro1100_Gly1102del) | 1278 | COL1A2 | Pathogenic | 74315103 | RCV000018804; | N | MedGen:C0268363,OMIM:166220,SNOMED CT:205497004 | 7 | 94056950 | 94056958 | NM_000089.3:c.3279_3287delTCCCCCTGG | NP_000080.2:p.Pro1100_Gly1102del | NC_000007.13:g.94056950_94056958delTCCCCCTGG | OMIM Allelic Variant:120160.0035 | C0268363 166220 Osteogenesis imperfecta with normal sclerae, dominant form | | |